Methylphenidate therapy improves cognition, mood, and function of brain tumor patients

Journal of Clinical Oncology

Volumn 16, Issue 7, 1998, Pages 2522-2527

  Meyers, Christina A ^a   Weitzner, Michael A ^b   Valentine, Alan D ^b   Levin, Victor A ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN ANTICOAGULANT; METHYLPHENIDATE; PHENOBARBITAL; PHENYTOIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BEHAVIOR DISORDER; BRAIN TUMOR; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG EFFECT; DRUG INDICATION; FEMALE; GLIOBLASTOMA; HUMAN; INSOMNIA; IRRITABILITY; MALE; MOTIVATION; NERVOUSNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TASK PERFORMANCE; TREATMENT OUTCOME;

EID: 0031804274     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.7.2522     Document Type: Article

References (50)

1. Levin VA, Leibel S, Gutin PH: Neoplasms of the central nervous system, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 5). Philadelphia, PA, Lippincott-Raven, 1997, pp 2022-2082
2. Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunction following surgery for intracerebral glioma: Influence of histopathology, lesion location, and treatment. J Neurooncol 30:61-69, 1996
3. Lilja Å, Brun A, Salford LG, et al: Neuropsychological indexes of a partial frontal syndrome in patients with nonfrontal gliomas. Neuropsychology 6:315-326, 1992
4. Archibald YM, Lunn D, Ruttan LA, et al: Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80:247-253, 1994
5. Hochberg FH, Slotnick B: Neuropsychologic impairment in astrocytoma survivors. Neurology 30:172-177, 1980
6. Imperato JP, Paleologos NA, Vich NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28:818-822, 1990
7. Lieberman AN, Foo SH, Ransohoff J, et al: Long term survival among patients with malignant brain tumors. Neurosurgery 10:450-453, 1982
8. Salander P, Karlsson T, Bergenheim T, et al: Long-term memory deficits in patients with malignant gliomas. J Neurooncol 25:227-238, 1995
9. Taphoorn MJB, Schiphorst AK, Snoek JF, et al: Cognitive functions and quality of life in patients with low-grade gliomas: The impact of radiotherapy. Ann Neurol 36:48-54, 1994
10. Grant R, Slattery J, Gregor A, et al: Recording neurological impairment in clinical trials of glioma. J Neurooncol 19:37-49, 1994
11. DeAngelis LM, Delattre J-Y, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989
12. Corn BW, Yousem DM, Scott CB, et al: White matter changes are correlated significantly with radiation dose. Cancer 74:2828-2835, 1994
13. Cummings JL: Introduction, in Cummings JL (ed): Subcortical Dementia. New York, NY, Oxford University, 1990, pp 3-16
14. Marin RS: Apathy: A neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243-254, 1991
15. Iversen LL. Dopamine receptors in the brain. Science 188:1084-1089, 1975
16. Simon H, Scatton B, Le Moal M: Dopaminergic A 10 neurons are involved in cognitive functions. Nature 286:150-151, 1980
17. Weitzner MA, Meyers CA, Valentine AD: Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7:347-350, 1995
18. DeLong R, Friedman H, Friedman N, et al: Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurology 7:462-463, 1992 (letter)
19. Faucett J, Busch KA: Psychostimulants in psychiatry, in Schatzberg AF, Nemeroff CB (eds): Textbook of Psychopharmacology. Washington, DC, American Psychiatric, 1995, pp 417-435
20. Masand PS, Tesar GE: Use of stimulants in the medically ill. Psychiatr Clin North Am 19:515-547, 1996
21. Zasler ND: Advances in neuropharmacological rehabilitation for brain dysfunction. Brain Inj 6:1-14, 1992
22. Nelson JC: Sympathomimetics, in Kaplan HI, Dadock BJ (eds): Comprehensive Textbook of Psychiatry (ed 6). Baltimore, MD, Williams & Wilkins, 1995, pp 2073-2079
23. Volkow ND, Wang GJ, Fowler JS, et al: Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors. Am J Psychiatry 154:50-55, 1997
24. Volkow ND, Wang GJ, Gatley SJ, et al: Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology 123:26-33, 1996
25. Lazarus LW, Moberg PJ, Langsley PR, et al: Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison. Arch Phys Med Rehabil 75:403-406, 1994
26. Rosenberg PB, Ahmed I, Hurwitz S: Methylphenidate in depressed medically ill patients. J Clin Psychiatry 52:263-267, 1991
27. Olin J, Masand P: Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 37:57-62, 1996
28. Plenger PM, Dixon CE, Castillo RM, et al: Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 77:536-540, 1996
29. Speech TJ, Rao SM, Osmon DC, et al: A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj 7:333-338, 1993
30. Bruera E, Miller MJ, Macmillan K, et al: Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48:163-166, 1992
31. Wilwerding MB, Loprinzi CL, Mailliard JA, et al: A randomized, cross-over evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 3:135-138, 1995
32. Brown GR: The use of methylphenidate for cognitive decline associated with HIV disease. Int J Psychiatry Med 25:21-37, 1995
33. Jenike MA: Treatment of affective illness in the elderly with drugs and electroconvulsive therapy. J Geriatr Psychiatry 22:77-112, 1989
34. Wroblewski BA, Leary JM, Phelan AM, et al: Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry 53:86-89, 1992
35. Wechsler D: Wechsler Adult Intelligence Scale-Revised. San Antonio, TX, Psychological Corp, 1981
36. Brandt J: The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychologist 5:125-142, 1991
37. Benton AL, Hamsher KS: Multilingual Aphasia Examination. Iowa City, IA, AJA Associates, 1989
38. Lezak MD: Neuropsychological Assessment. New York, NY, Oxford University, 1995
39. Beck AT, Steer RA: Beck Depression Inventory. San Antonio, TX, Psychological Corp, 1993
40. Spielberger C, Gorsuch R, Lushene R: State-Trait Anxiety Inventory. Palo Alto, CA, Consulting Psychologists, 1970
41. Linacre JM, Heinemann AW, Wright BD, et al: The structure and stability of the Functional Independence Measure. Arch Phys Med Rehabil 75:127-132, 1994
42. Levin VA, Crafts DC, Norman DM, et al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47:329-335, 1977
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (ed 4). Washington, DC, American Psychiatric Association, 1994
44. Meyers CA, Grous JJ, Ford KM, et al: Multifaceted models for assessing quality of life in brain cancer therapy trials. Drug Inform J 30:856-857, 1996 (abstr)
45. Marin RS: Apathy: Concept, syndrome, neural mechanisms, and treatment. Semin Clin Neuropsychiatry 1:304-314, 1996
46. Marin RS: Apathy - Who cares? An introduction to apathy and related disorders of diminished motivation. Psychiatric Ann 27:18-23, 1997
47. Kalivas PW, Churchill L, Kliteneck MA: The circuitry mediating the translation of motivational stimuli into adaptive motor responses, in Kalivas PW, Barnes CD (eds): Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL, CRC, 1993, pp 237-287
48. Marin RS, Firinciogullari MS, Biedrzycki RC: Group differences in the relationship between apathy and depression. J Nerv Ment Dis 182:235-239, 1994
49. Kalivas PW, Barnes CD: Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL, CRC, 1993
50. Morgenson GJ, Brudzynski SM, Wu M, et al: From motivation to action: A review of limbic, nucleus accumbens, ventral pallidum. pedunculopontine nucleus circuitries involved in limbic-motor integration, in Kalivas PW, Barnes CD (eds): Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL, CRC, 1993, pp 193-236